VXRT

Vaxart Inc
1.10
-0.01 (-0.90%)

Vaxart Inc. (VXRT) Fundamentals

Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.
SHARE INFORMATION
Market Cap$ 145,686,485
Shares Outstanding131,249,086
Float117,292,799
Percent Float89.37%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 892,000
Latest Fiscal EPS$ -0.58
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment CashCash
HOLDERS
Institutions277
Institutional Holdings Date2022-12-31
Institutional Bought Previous 3 Months8,092,138
Institutional Holdings Percent68.0%
Institutional Sold Previous 3 Months16,250,263
Insider Holdings Date2022-12-31
Insider Bought Previous 3 Months20,000
Insider Holdings Percent2.4
Insider Sold Previous 3 Months1,500
Insider Shares Owned3,190,817
TRADING INFO
52 Week High$ 5.43
52 Week Low$ 0.73
52 Week High Change$ -74.19
21 Day Moving Average$ 1.0488
21 Day Extended Moving Average$ 1.0769
50 Day Moving Average$ 1.1103
50 Day Extended Moving Average$ 1.2052
200 Day Moving Average$ 2.6297
200 Day Extended Moving Average$ 2.5796
10 Day Average Volume1,797,192
20 Day Average Volume2,257,611
30 Day Average Volume3,437,707
50 Day Average Volume3,271,263
Alpha0.052324
Beta0.7834
Standard Deviation0.557148
R20.005748
7 Day Price Change$ -0.02
7 Day Percent Change-1.77%
21 Day Price Change$ 0.1357
21 Day Percent Change13.93%
30 Day Price Change$ 0.3603
30 Day Percent Change48.06%
Month to Date Price Change$ 0.1491
Month to Date Percent Change15.52%
Quarter to Date Price Change$ 0.1491
Quarter to Date Percent Change15.52%
180 Day Price Change$ -2.69
180 Day Percent Change-70.79%
200 Day Price Change$ -3.13
200 Day Percent Change-73.82%
Year to Date Price Change$ 0.1491
Year to Date Percent Change15.52%

Vaxart Inc. (VXRT) Key Ratios

PROFITABILITY
EBIT Margin-64,908.2%
EBITDA Margin-61,692.5%
Pre-Tax Profit Margin-5,953.4%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 85,000
Revenue Per Share$ 0.0006
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book1.40
Total Debt To Equity0.20
Int Coverage-77.50
Current Ratio3.20
Leverage Ratio1.30
Quick Ratio5.30
Long Term Debt To Capital0.15
VALUATION MEASURES
PE Ratio-1.30
Enterprise Value$ 53,087,485
Price to Sales1,713.9586
Price to Free Cash-2.00
PE High Last 5 Years-1.80
Price To Book1.20
Price To Cash Flow20.10
PE Low Last 5 Years-13.90
Price to Tangible Book1.40
MANAGEMENT EFFECTIVENESS
Receivables Turnover2.80
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-55.11
Return on Equity-70.70
Return on Capital-57.55

Vaxart Inc. (VXRT) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorWithumSmith+Brown, PC
CEOAndrei Floroiu
Emplyoees110
Last AuditUQ
CIK0000072444
IndustryBiotechnology
SectorHealthcare
NAICSBiological Product (except Diagnostic) Manufacturing(325414)
CONTACT INFO
Address170 Harbor Way
Suite 300
South San Francisco, CA 94080
Websitehttps://www.vaxart.com
Facsimile+1 650 871-8580
Telephone+1 650 550-3500
Email-


Your Recent History
NASDAQ
VXRT
Vaxart
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.